Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors.
Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors.
复制标题
鉴定对 Cu2 介导的甘氨酸 α1 受体抑制至关重要的残基。
DOI:
10.1016/j.neuropharm.2006.05.009
复制
发表时间:
2006
影响因子:
4.7
通讯作者:
Huang,Renqi
中科院分区:
文献类型:
--
作者:
Chen,Zhenglan;Dillon,GlennH;Huang,Renqi
Endogenous divalent cations Cu2+and Zn2+suppress the activity of glycine receptors (glyRs). Whereas residues critical for the effects of Zn2+on glyRs have been identified, little is known about the determinants of Cu2+-mediated inhibition. In the present studies, we have assessed the potential commonality of Zn2+and Cu2+-mediated inhibition of glyRs. Cu2+potently inhibited recombinant human glycine α1 receptors, with an IC50of 4.1±0.7μM. Systematic mutation of extracellular histidine residues revealed that mutation H215A greatly reduced the inhibitory modulation by Cu2+. Substitution of H215 with C produced receptors with Cu2+sensitivity similar to the wild type. Furthermore, modification of H215C with a thio-specific reagent, [2-(trimethylammonium)ethyl] methanethiosulfonate bromide (MTSET), reduced Cu2+sensitivity of H215C receptors. However, mutation of other extracellular histidine residues including H107 and H109, which are known inhibitory Zn2+coordination sites, failed to influence inhibition of glycine currents by Cu2+. Moreover, mutation to alanine of two threonine residues (T112, T133) critical for Zn2+inhibition had no effect (T133A) or only partial inhibitory effects (T112A) on Cu2+-induced inhibition. The double mutation, T112A/H215A, caused greater effects on Cu2+-mediated inhibition than either mutation alone. In addition, the glycine currents recorded from T112A/H215A mutant receptors were significantly potentiated by low concentrations of Cu2+. Our results have identified critical determinants of Cu2+-mediated inhibition of glyRs. Moreover, we demonstrate for the first time a clear difference in residues responsible for Cu2+-mediated compared to Zn2+-mediated inhibition of glyRs.